Browsing: Disease Discoveries

An epigenetic inhibitor increased immune system activity in patients with ovarian cancer.

Exposure to light during sleep was associated with obesity, diabetes and high blood pressure in older adults, according to a recent study.

Damage to particular regions of the brain may influence addiction behaviors, providing insight into potential therapeutic targets for substance use disorders.

Bicarbonate ions are required for cell growth in some cancers, according to a Northwestern Medicine study.

Designed to target AMPAR receptors in the brain, the medication — called perampanel — also modulates kainate receptors.

A new study provides evidence that blood epigenetic biomarkers contain “snapshots” of past cardiovascular health exposures and behavior at the molecular level.

A deep learning model has discovered genetic variations in cancer that are undetectable in traditional genome sequencing.

Northwestern Medicine investigators have continued to examine COVID-19, from the impact of prone positioning during treatment to vaccine protection against the Omicron variant in children.

Investigators have discovered a new method to determine whether individual genetic variants in the epilepsy-associated gene SZT2 cause the neurodevelopmental disorder, according to a Northwestern Medicine study.

A newly discovered inhibitor of a common cancer-causing protein operates selectively, reducing expression of genes that fuel rampant cell proliferation, and altering the epigenome, according to a recent study.